Evidence map›Paper›PMID 24828896›Full record

ArticleJournal of neurology, neurosurgery, and psychiatry2014

Autosomal dominant eccentric core disease caused by a heterozygous mutation in the MYH7 gene.

Norma B Romero, Ting Xie, Edoardo Malfatti, Ursula Schaeffer, Johann Böhm, Bin Wu, Fengping Xu, Samy Boucebci, Stéphane Mathis, Jean-Philippe Neau and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, neurosurgery, and psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Journal of neurology, neurosurgery, and psychiatry · 2025
    Article
  3. MYH7 in cardiomyopathy and skeletal muscle myopathy.Molecular and cellular biochemistry · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 6 countries.

Norma B RomeroNeuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France Inserm, U974, Paris, France University Pierre et Marie Curie- Paris 6, UM 76, CNRS, UMR 7215, Myology Institute, IFR14, Paris, France Centre de référence de Pathologie Neuromusculaire Paris-Est, Institut de Myologie, GHU La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Ting XieDepartment of Translational Medicine and Neurogenetics, IGBMC, Illkirch, France Inserm, U964, Illkirch, France CNRS, UMR7104, Illkirch, France Université de Strasbourg, Illkirch, France Collège de France, chaire de génétique humaine, Illkirch, France.
Edoardo MalfattiNeuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France Inserm, U974, Paris, France University Pierre et Marie Curie- Paris 6, UM 76, CNRS, UMR 7215, Myology Institute, IFR14, Paris, France Centre de référence de Pathologie Neuromusculaire Paris-Est, Institut de Myologie, GHU La Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France Department of Neurological, Neurosurgical, and Behavioral Sciences, University of Siena, Siena, Italy.
Ursula SchaefferDepartment of Translational Medicine and Neurogenetics, IGBMC, Illkirch, France Inserm, U964, Illkirch, France CNRS, UMR7104, Illkirch, France Université de Strasbourg, Illkirch, France Collège de France, chaire de génétique humaine, Illkirch, France.
Johann BöhmDepartment of Translational Medicine and Neurogenetics, IGBMC, Illkirch, France Inserm, U964, Illkirch, France CNRS, UMR7104, Illkirch, France Université de Strasbourg, Illkirch, France Collège de France, chaire de génétique humaine, Illkirch, France.
Bin WuBGI-Shenzhen, Shenzhen, China.
Fengping XuBGI-Shenzhen, Shenzhen, China.
Samy BoucebciService de Neurologie and Pôle Imagerie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Stéphane MathisService de Neurologie and Pôle Imagerie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Jean-Philippe NeauService de Neurologie and Pôle Imagerie, Centre Hospitalier Universitaire de Poitiers, Poitiers, France.
Nicole MonnierLaboraroire de Biochimie et Génétique moléculaire, IBP, CHU Grenoble, Grenoble, France.
Michel FardeauNeuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France University Pierre et Marie Curie- Paris 6, UM 76, CNRS, UMR 7215, Myology Institute, IFR14, Paris, France.
Jocelyn LaporteDepartment of Translational Medicine and Neurogenetics, IGBMC, Illkirch, France Inserm, U964, Illkirch, France CNRS, UMR7104, Illkirch, France Université de Strasbourg, Illkirch, France Collège de France, chaire de génétique humaine, Illkirch, France.
Centre Hospitalier Universitaire de Poitiers · FRBGI Group (China) · CNCanadian Nautical Research Society · CASorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire de Grenoble · FRCollège de France · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutosomal dominant (AD) central core disease (CCD) is a congenital myopathy characterised by the presence of cores in the muscle fibres which correspond to broad areas of myofibrils disorganisation, Z-line streaming and lack of mitochondria. Heterozygous mutations in the RYR1 gene were observed in the large majority of AD-CCD families; however, this gene was excluded in some of AD-CCD families.

objectiveTo enlarge the genetic spectrum of AD-CCD demonstrating mutations in an additional gene. PATIENTS AND

methodsFour affected AD family members over three generations, three of whom were alive and participate in the study: the mother and two of three siblings. The symptoms began during the early childhood with mild delayed motor development. Later they developed mainly tibialis anterior weakness, hypertrophy of calves and significant weakness (amyotrophic) of quadriceps. No cardiac or ocular involvement was noted.

resultsThe muscle biopsies sections showed a particular pattern: eccentric cores in type 1 fibres, associated with type 1 predominance. Most cores have abrupt borders. Electron microscopy confirmed the presence of both unstructured and structured cores. Exome sequencing analysis identified a novel heterozygous missense mutation p.Leu1723Pro in MYH7 segregating with the disease and affecting a conserved residue in the myosin tail domain.

conclusionsWe describe MYH7 as an additional causative gene for AD-CCD. These findings have important implications for diagnosis and future investigations of AD-congenital myopathies with cores, without cardiomyopathy, but presenting a particular involvement of distal and quadriceps muscles.

Indexed as

AdultAgedCardiac MyosinsFemaleGenetic Predisposition to DiseaseHeterozygoteHumansMaleMuscle Fibers, Slow-TwitchMutation, MissenseMyopathy, Central CoreMyosin Heavy ChainsPedigreeRadiographyCardiac MyosinsMYH7 protein, humanMyosin Heavy ChainsMUSCLE DISEASEMYOPATHYNEUROPATHOLOGY, MUSCLE

Identifiers

PMID24828896
PMCPMC4173876
OpenAlexW2012721296

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.